Skip to content
Skip to main navigation
Skip to 1st column
Skip to 2nd column
ADHD-Europe
Home
ADHD-Europe
What is AD/HD?
Objectives
Sponsorship & membership
Who is who?
Board
Members
Friends of ADHD-Europe
Contact
News
Participation
Calendar
Projects EU
Contribution green paper 06
Avant la lettre
Common Issue Texts
Disorder
Diagnosis
Treatment
Comorbidities
Policies & guidelines
Results of research
Surveys
Links
Austria
Belgium
Croatia
Denmark
Finland
You are here:
Home
Common Issue Texts
Treatment
Treatment
#
Article Title
Hits
1
Questions and answers on the review of medicines containing methylphenidate
495
2
Recommended information in Summaries of Characteristics for methylphenidate-containing products
448
3
Recommendations for safer use of Ritalin and other methylphenidate-containing medicines in the EU
428
4
Secondary Evaluations of MTA 36-Month Outcomes: Propensity Score and Growth Mixture Model Analyses
539
5
3-Year Follow-up of the NIMH MTA Study
592
6
Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up
545
7
Delinquent Behavior and Emerging Substance Use in the MTA at 36 Months: Prevalence, Course, and Treatment Effects
527
8
Drugs 'of no benefit' to hyperactive children
587
back